The tumor microenvironment (TME) of HR+/HER2- breast cancer cells is composed of CD3D+ T cells, CD68+ macrophages, COL1A1+ fibroblasts, and FLT1+ endothelial cells. The gene discussed is CD68; the disease is breast carcinoma.